Suscribete

Antibodies to Intracellular Cancer Antigens Combined with Chemotherapy Enhance Anti-cancer Immunity

Pre-clinical study by scientists funded by Cancer Research Institute and Ludwig Institute for Cancer Research confirmed that...

Lloyd J. Old, MD, Father of Modern Tumor Immunology, Dies at 78 of Prostate Cancer

CRI announced today its founding scientific and medical director Lloyd J. Old, MD, regarded as the “Father...

Critical Value Demonstrated for Immune Assay Harmonization

The Association for Cancer Immunotherapy Immunoguiding Program and the Cancer Immunotherapy Consortium of CRI published a joint...

Cancer Immunotherapy Consortium Appoints New Leadership

Drs. James P. Allison, chair of the immunology program at Memorial Sloan-Kettering Cancer Center, and Axel Hoos,...

25th Annual CRI Awards Dinner Honors Outstanding Contributions to Cancer Immunotherapy

CRI hosted its 25th Annual Awards Dinner on Monday, October 3, 2011, where 290 guests joined CRI...

Collaborative Partnership Pioneers Model to Improve Clinical Success of Cancer Immunotherapies

The Cancer Immunotherapy Consortium of the Cancer Research Institute and the Association for Cancer Immunotherapy have issued...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.